A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer
NCT07492381 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-04-07
Summary
The primary objective of this study is to evaluate the safety and effectiveness of PFA in patients with localized prostate cancer.
Conditions
Interventions
- DEVICE
-
ALPFA BPH PFA System
Single arm
Sponsors & Collaborators
-
ALPFA Medical
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2027-06-30
- Completion
- 2029-12-31
More Related Trials
-
Evaluation of Symptom-specific Goal Achievement
NCT00836823 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
NCT02244268 ·Status: COMPLETED
-
Benign Prostatic Hyperplasia in Taiwan
NCT00941343 ·Status: COMPLETED ·Phase: NA
-
Prostate Stimulation for Sexual Dysfunction
NCT05468931 ·Status: RECRUITING ·Phase: NA
-
Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
NCT00542165 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
NCT02592473 ·Status: UNKNOWN ·Phase: NA
-
Neuflo System for the Treatment of BPH
NCT05884580 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NCT05757687 ·Status: RECRUITING ·Phase: NA
-
Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH
NCT02683980 ·Status: COMPLETED ·Phase: NA
-
The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients
NCT00696761 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
NCT00540891 ·Status: COMPLETED ·Phase: PHASE3
-
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
NCT02026908 ·Status: COMPLETED ·Phase: NA
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
NCT00347061 ·Status: COMPLETED ·Phase: PHASE3
-
Prostatic Artery Embolization for Benign Prostatic Obstruction
NCT03099421 ·Status: COMPLETED ·Phase: NA
-
RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up
NCT05784558 ·Status: WITHDRAWN
-
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
NCT00575913 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
NCT01294150 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT00709488 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
NCT02245503 ·Status: COMPLETED
-
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
NCT00486785 ·Status: COMPLETED ·Phase: PHASE4
-
UroLift System With SAbR for Prostate Cancer and BPH
NCT05311527 ·Status: COMPLETED ·Phase: NA
-
ALA and Prostate Cancer
NCT00309439 ·Status: UNKNOWN ·Phase: PHASE2